false 0001823857 0001823857 2023-12-22 2023-12-22 0001823857 VHAQ:UnitsMember 2023-12-22 2023-12-22 0001823857 us-gaap:CommonStockMember 2023-12-22 2023-12-22 0001823857 VHAQ:WarrantsMember 2023-12-22 2023-12-22 0001823857 us-gaap:RightsMember 2023-12-22 2023-12-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 22, 2023

 

Viveon Health Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-39827   85-2788202
(State or other jurisdiction
of  incorporation)		  

(Commission

File Number)

   (I.R.S. Employer
Identification No.)

 

3480 Peachtree Road NE
2nd Floor – Suite #112
Atlanta, Georgia 30326

(Address of Principal Executive Offices and Zip Code)

 

Registrant’s telephone number, including area code: (404) 861-5393

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units   VHAQU   NYSE American, LLC
Common Stock   VHAQ   NYSE American, LLC
Warrants   VHAQW   *
Rights   VHAQR   NYSE American, LLC

 

* The Warrants trade on the OTC Pink Marketplace maintained by the OTC Markets Group, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

 

On December 22, 2023, Viveon Health Acquisition Corp. (the “Company”) received a letter from the NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Common Stock, Units and Rights (collectively, the “Securities”) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company specified in its registration statement. At this time, the Securities have not been suspended and will continue to trade.

 

As indicated in the letter, the Company has a right to a review of the delisting determination by a Committee of the Board of Directors of the Exchange, provided a written request for such review is requested no later than December 29, 2023. The Company intends to make such request.

 

Cautionary Statement Regarding Forward-Looking Statements

 

Statements contained in this Current Report on Form 8-K that are not historical facts may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties. The Company does not undertake any obligation to update forward-looking statements as a result of new information, future events or developments or otherwise, except as required by applicable law or regulation.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 26, 2023

 

Viveon Health Acquisition Corp.  
     
By: /s/ Jagi Gill  
Name: Jagi Gill  
Title: Chief Executive Officer  

 

 

 

v3.23.4
Cover
Dec. 22, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 22, 2023
Entity File Number 001-39827
Entity Registrant Name Viveon Health Acquisition Corp.
Entity Central Index Key 0001823857
Entity Tax Identification Number 85-2788202
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3480 Peachtree Road NE
Entity Address, Address Line Two 2nd Floor
Entity Address, Address Line Three Suite #112
Entity Address, City or Town Atlanta,
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30326
City Area Code (404)
Local Phone Number 861-5393
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units [Member]  
Title of 12(b) Security Units
Trading Symbol VHAQU
Security Exchange Name NYSEAMER
Common Stock [Member]  
Title of 12(b) Security Common Stock
Trading Symbol VHAQ
Security Exchange Name NYSEAMER
Warrants [Member]  
Title of 12(b) Security Warrants
Trading Symbol VHAQW
Rights [Member]  
Title of 12(b) Security Rights
Trading Symbol VHAQR
Security Exchange Name NYSEAMER
Viveon Health Acquisition (AMEX:VHAQ)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Viveon Health Acquisition.
Viveon Health Acquisition (AMEX:VHAQ)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Viveon Health Acquisition.